Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-038858

PULSE BIOSCIENCES, INC. · PLSE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Darrin Uecker
Officer — CEO and President · Director
Period of report
Jun 7, 2017
Accepted (ET)
Jun 9, 2017 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001625101

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jun 7, 2017A160,974$0.00A160,974D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F2$30.99Jun 7, 2017A187,286AJun 7, 2017Jun 7, 2027Common Stock187,286187,286D
Stock Option (right to buy)F3$30.99Jun 7, 2017A195,000AJun 7, 2017Jun 7, 2027Common Stock195,000195,000D

Explanation of responses